Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mervi H. Lankinen"'
Autor:
Urs Wirthmüller, Jean‐François Viret, Susan J. Best, Joliette Coste, Andreas Glauser, Mervi H. Lankinen, Christine Defer, Elizabeth M. Dax, Jean-Pierre Allain, Barbara L. Masecar, Volkmar Schottstedt, H. Theo M. Cuypers, Marcia da Silva Cardoso, Susan L. Stramer, Harry van Drimmelen, Lena Grillner, Pierre Moncharmont, P. Nico Lelie, Micha Nübling, Catherine A. Hyland
Publikováno v:
Transfusion. 42(5)
BACKGROUND: The FDA requirement for sensitivity of viral NAT methods used in blood screening is a 95-percent detection limit of 100 copies per mL, whereas the NAT screening system should have a sensitivity of at least 5000 copies per mL per individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55f552e162b11d2ae03f68b2efd9a16
https://pubmed.ncbi.nlm.nih.gov/12084160
https://pubmed.ncbi.nlm.nih.gov/12084160
